Christopher Yallop

First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1

Kathryn E. Stephenson, Michael C. Keefer, Catherine A. Bunce et al. · PLoS ONE · 2018 · 36 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Enhancing viral vaccine production using engineered knockout vero cell lines – A second look

Femke Hoeksema, Jon Karpilow, Alfred Luitjens et al. · Vaccine · 2018 · 19 citations · Full text

Life Sciences, Biotechnology, Infectious Diseases +15

Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery

Prashant Kumar, Swathi R. Pullagurla, Ashaben Patel et al. · Journal of Pharmaceutical Sciences · 2020 · 14 citations · Full text

Veterinary Medicine, Infectious Diseases, Bioavailability +16

Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries

Prashant Kumar, Ravi Shukla, Ashaben Patel et al. · Human Vaccines & Immunotherapeutics · 2021 · 13 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Pharmaceutics +17

Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine

Ahd Hamidi, Femke Hoeksema, Pim Velthof et al. · Vaccine · 2021 · 11 citations · Full text

Veterinary Medicine, Biotechnology, Infectious Diseases +17